Clinical trial

A Study of LY2605541 and Glargine and Exercise in Participants With Type 1 Diabetes

NCT01784211

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-02-01

PhasePHASE1

Study timeline

Study start (unknown)2013-02-01Date precision: month

Registry last updated2019-03-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 1unresolved

Interventions

LY2605541DRUG

Insulin GlargineDRUG · verified · RxNorm: insulin glargine

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01784211 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.